Oakland, California--(Newsfile Corp. - January 11, 2021) - The Magic Mushroom Company (OTCP Pink: MINE) specializing in growing, research, production and distribution of psilocybin mushrooms, announced today that Paul Hoonjan has been appointed as its new President.
KCSA Strategic Communications to Host Inaugural KCSA Psychedelics Investor Conference on January 26-27, 2021
KCSA Communications hosts an investment conference featuring Rick Doblin (MAPS) as a keynote speaker.
Airdrie cancer patient first Albertan to undergo legal magic mushroom therapy
Tony White called his therapy session powered by magic mushrooms “a good trip.”
Further Research into Psilocybin Opens New Doors for Treatment
NEW YORK, Jan. 7, 2021 /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others.
BetterLife Pharma forms psychedelic research advisory board and taps industry veteran Hattie Wells as its first member
BetterLife Pharma Inc tapped the experience of psychedelic pioneer Hattie Wells to join its new psychedelic research advisory board.
Mind Cure Tackles Mental Health Crisis On Two Fronts
Psychedelic Stock Watch connects the dots regarding Mind Cure's clinic launch and latest product development news.
Mind Cure Announces Build-Out of Digital Therapeutics,iSTRYM: A Technology Platform for Mental Wellness Optimization & PsychedelicResearch
Mind Cure's iSTRYM digital therapeutics platform is designed to provide real-time data regarding patient care.
Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products
Numinus announces a product development agreement with Optimi Health Corp.
CYBIN Provides Update on Patent Filings & Development of Therapeutics Program
Cybin Corp updates investors on its IP development
North America Psychedelic Drugs Market Could Exceed $6.8 Billion By 2027
PALM BEACH, Fla., Jan. 6, 2021 /PRNewswire/ -- In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales.
From USciences to Argentina and beyond, the son of filmmaker Errol Morris explores psychedelics for VICE TV
While the world waited breathlessly this fall for anything resembling definitive results from the Nov. 3 presidential election, one early winner seemed clear: drugs.
New Psychedelics ETF Is Another Sector Milestone
The new Horizons Psychedelic Stock Index ETF will add new demand and increased visibility for psychedelic drug stocks.